James M. Small

1.2k total citations
18 papers, 857 citations indexed

About

James M. Small is a scholar working on Epidemiology, Dermatology and Oncology. According to data from OpenAlex, James M. Small has authored 18 papers receiving a total of 857 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 4 papers in Dermatology and 4 papers in Oncology. Recurrent topics in James M. Small's work include Nonmelanoma Skin Cancer Studies (4 papers), Cancer and Skin Lesions (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). James M. Small is often cited by papers focused on Nonmelanoma Skin Cancer Studies (4 papers), Cancer and Skin Lesions (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). James M. Small collaborates with scholars based in United States. James M. Small's co-authors include Mark F. Brady, Patricia S. Braly, Gregory P. Sutton, Paul R. Kucera, Theodore H. Niemann, Ronald D. Alvarez, Franco M. Muggia, Peter G. Rose, Stacy Nerenstone and Daniel L. Clarke‐Pearson and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

James M. Small

18 papers receiving 826 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James M. Small United States 10 605 426 287 188 88 18 857
R. Barakat United States 19 842 1.4× 692 1.6× 419 1.5× 351 1.9× 67 0.8× 47 1.3k
Guy M. Boike United States 17 406 0.7× 295 0.7× 434 1.5× 127 0.7× 83 0.9× 31 884
Selina Bannoo United Kingdom 5 950 1.6× 766 1.8× 468 1.6× 244 1.3× 91 1.0× 5 1.3k
Ilana Yanai‐Inbar Israel 18 362 0.6× 222 0.5× 205 0.7× 170 0.9× 75 0.9× 51 870
Ann Marie Swart United Kingdom 13 903 1.5× 453 1.1× 321 1.1× 436 2.3× 166 1.9× 22 1.3k
Emanuela Mancini Italy 23 409 0.7× 443 1.0× 637 2.2× 227 1.2× 111 1.3× 51 1.2k
Ismail A. Al‐Badawi Saudi Arabia 18 283 0.5× 269 0.6× 214 0.7× 182 1.0× 152 1.7× 70 882
Sarikapan Wilailak Thailand 16 311 0.5× 204 0.5× 305 1.1× 242 1.3× 120 1.4× 59 870
Leslie Walton United States 13 222 0.4× 271 0.6× 348 1.2× 191 1.0× 97 1.1× 23 832
Toru Tase Japan 17 292 0.5× 305 0.7× 398 1.4× 167 0.9× 104 1.2× 44 967

Countries citing papers authored by James M. Small

Since Specialization
Citations

This map shows the geographic impact of James M. Small's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Small with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Small more than expected).

Fields of papers citing papers by James M. Small

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. Small. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Small. The network helps show where James M. Small may publish in the future.

Co-authorship network of co-authors of James M. Small

This figure shows the co-authorship network connecting the top 25 collaborators of James M. Small. A scholar is included among the top collaborators of James M. Small based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. Small. James M. Small is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Small, James M., et al.. (2024). Potential Therapeutic Targets for Combination Antibody Therapy Against Staphylococcus aureus Infections. Antibiotics. 13(11). 1046–1046. 10 indexed citations
3.
Small, James M., Jessica E. Pullan, Seth Winfree, et al.. (2023). An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic. PLoS ONE. 18(11). e0289183–e0289183. 5 indexed citations
4.
Small, James M., et al.. (2022). Bacterial Involvement in Progression and Metastasis of Colorectal Neoplasia. Cancers. 14(4). 1019–1019. 25 indexed citations
5.
Small, James M., et al.. (2022). Bacterial Involvement in Progression and Metastasis of Adenocarcinoma of the Stomach. Cancers. 14(19). 4886–4886. 9 indexed citations
6.
Brooks, Amanda E., et al.. (2021). Potential Therapeutic Targets for Combination Antibody Therapy against Pseudomonas aeruginosa Infections. Antibiotics. 10(12). 1530–1530. 15 indexed citations
7.
Small, James M., et al.. (2021). Inflammatory Myofibroblastic Tumor of the Larynx: Report of a Case. Journal of Voice. 37(5). 799.e17–799.e19. 2 indexed citations
8.
Wilson, Ashley, James M. Small, David M. Perry, et al.. (2019). Keratinocyte Carcinoma and Risk for Another Type of Cancer: Assessment of a Dose-response Relationship. Anticancer Research. 39(9). 5083–5087. 1 indexed citations
9.
Motamarry, Anjan, Ayele H. Negussie, James M. Small, et al.. (2019). Real-time fluorescence imaging for visualization and drug uptake prediction during drug delivery by thermosensitive liposomes. International Journal of Hyperthermia. 36(1). 816–825. 27 indexed citations
10.
Small, James M., Kristin Wallace, Elizabeth G. Hill, et al.. (2019). A cohort study of personal and family history of skin cancer in relation to future risk of non-cutaneous malignancies. Cancer Causes & Control. 30(11). 1213–1221. 2 indexed citations
11.
Small, James M., Kent Armeson, David M. Perry, et al.. (2016). Family history of cutaneous and noncutaneous malignancies in relation to the risk of keratinocyte carcinoma coupled with another type of cancer: A case-control study. Journal of the American Academy of Dermatology. 75(5). 1066–1068.e7. 1 indexed citations
12.
Small, James M., Virginia Barton, Bruce E. Peterson, & Anthony J. Alberg. (2016). Keratinocyte Carcinoma as a Marker of a High Cancer-Risk Phenotype. Advances in cancer research. 130. 257–291. 16 indexed citations
13.
Egan, Brent M., et al.. (2014). The Growing Gap in Hypertension Control Between Insured and Uninsured Adults. Hypertension. 64(5). 997–1004. 47 indexed citations
14.
Rose, Peter G., Stacy Nerenstone, Mark F. Brady, et al.. (2004). Secondary Surgical Cytoreduction for Advanced Ovarian Carcinoma. New England Journal of Medicine. 351(24). 2489–2497. 245 indexed citations
15.
Brady, M F, D. Clarke-Pearson, George J. Olt, et al.. (2004). Operative morbidity following primary and interval debulking surgery for advanced ovarian cancer. Journal of Clinical Oncology. 22(14_suppl). 5010–5010. 1 indexed citations
16.
Muggia, Franco M., Patricia S. Braly, Mark F. Brady, et al.. (2000). Phase III Randomized Study of Cisplatin Versus Paclitaxel Versus Cisplatin and Paclitaxel in Patients With Suboptimal Stage III or IV Ovarian Cancer: A Gynecologic Oncology Group Study. Journal of Clinical Oncology. 18(1). 106–106. 436 indexed citations
17.
Small, James M., et al.. (1986). The frequency of fungal involvement in abnormal vocal cord biopsy specimens.. PubMed. 110(2). 141–3. 2 indexed citations
18.
Small, James M., James M. Holmes, & R. C. Connolly. (1953). The Prognosis and Role of Surgery in Spontaneous Intracranial Haemorrhage. BMJ. 2(4845). 1072–1075. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026